110 results
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
in satisfaction of a sale by the Holder of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock
8-K
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
to the satisfaction of customary closing conditions. The Company intends to use these net proceeds received from the Inducement Transaction for general working capital
8-K
EX-4.1
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
8-K
EX-4.2
dh5eb
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
cd7ow5
3 Jan 24
Changes in Registrant's Certifying Accountant
4:30pm
8-K
EX-4.2
ydx7bs12b1o p17rbd5m
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.3
0z6jpk7 ev
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-99.1
fojffc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.1
1fh208ocniyj6vub
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-10.1
600vtu6 wzlchj
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
nme0jpwew
2 Oct 23
Prospectus supplement for primary offering
4:52pm
8-K
zjtagvf9 njjmd
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-1.1
mb1y1ptcms a8q38
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-5.1
fc1d2j
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-3.1
ct0n9
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm